SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in GANX — Gain Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in GANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$158,757
-$677,900 QoQ
Shares Held
78,206
-81.9% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 49 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Derivatives in GANX
reported options exposure · as of Jun 30, 2026CallValue
$58,667
CallShares
28,900
PutValue
$72,471
PutShares
35,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. GANX ranks #249 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in GANX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,471 | 35,700 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $158,757 | 78,206 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $58,667 | 28,900 | Call | Other | 2026-08-14 | |
| 2026-03-31 | $836,657 | 431,267 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $74,302 | 38,300 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $45,080 | 14,000 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $98,532 | 30,600 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $2,203,603 | 684,349 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $142,369 | 80,435 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $143,191 | 79,551 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $68,220 | 37,900 | Call | Other | 2025-08-14 | |
| 2025-03-31 | $164,179 | 85,958 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $101,332 | 46,913 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $17,800 | 10,000 | Call | Defined | 2024-11-14 | |
| 2024-03-31 | $50,895 | 13,500 | Put | Defined | 2024-05-07 | |
| 2024-03-31 | $62,582 | 16,600 | Call | Defined | 2024-05-07 | |
| 2024-03-31 | $162,343 | 43,062 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $112,642 | 34,500 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $213,941 | 65,226 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $312,659 | 69,790 | Shares | Defined | 2023-08-11 | |
| 2023-06-30 | $60,032 | 13,400 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $99,456 | 22,200 | Put | Defined | 2023-08-11 | |
| 2023-03-31 | $73,129 | 15,172 | Shares | Defined | 2023-05-16 | |
| 2021-12-31 | $105,108 | 19,357 | Shares | Defined | 2022-04-05 | |
| No filing history on record for this holder in this stock. | ||||||